IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Genius — OpenServe

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

OpenServe Drive OpenServe Inbox OpenServe Write OpenServe Studio OpenServe Projects OpenServe Focus OpenServe Mindmaps Teams OpenServe CRM Site Builder Whiteboard

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Popular
Elections

Genius — OpenServe

Pulsar Helium names David T. Young as CFO and director — Sep 21, 2026Pulsar Helium Inc. appointed David T. Young as chief financial officer and a member of the board, with Dan O’Brien transitioning to vice president of finance, effective September 21, 2026. Young brings more than 25 years in energy and infrastructure, including leadership at Royal Helium during its restructuring, and will receive a substantial equity package to align with shareholders as the company advances its Topaz and other helium projects.

+3

Rachel Meyers O’Brien stepping into the VP finance role keeps continuity while adding fresh leadership at the top.

Crystalys Therapeutics raises $130M Series B — Jul 22, 2026Crystalys Therapeutics has raised a $130 million Series B led by Frazier Life Sciences with participation from multiple investors to fund late-stage global trials and commercialization plans for dotinurad, its URAT1 inhibitor for gout. The financing backs the RUBY, TOPAZ, and AMETHYST studies and aims to accelerate regulatory milestones and commercial readiness across the U.S. and Europe as the company positions dotinurad as a best-in-class option between first-line therapies and last-line treatments.

0